Bioxytran Inc (BIXT)

[Ecomike]

The trials in India show that their galectin product stops the ability of the virus to infect cells and thus eliminates all signs of Covid19 in 3 days, in early trials.

Still needs to do the phase III Human trials. Looks like they will focus on reduced transmission instead of reduced deaths and reduced hospital ICU cases as the latest versions of Covid19 are now a transmission stopping issue, and not so much a mass death issue. It is also a long haul health issue, so it would be interesting to see it tested on those cases...

Rvvtf, one that is close to the end of an FDA covid19 EUA trial repurposing an RA drug started their trials on mild cases and reduced hospitalizations for Wuhan Covid and Covid-D, , but they are now trying to change the end points to match the reality of the new strains, Omicron.... and targeting faster end of symptoms....

I own shares in both. In fact, I think both could be used together, dealing with 2 separate parts of the covid problems. Long story for another post someday...